Toxicological analysis of Pb and Cd by ET AAS in local anaesthetics for teething (teething gels) based on herbs available in Polish pharmacies by Jurowski, Kamil et al.
Accepted Manuscript
Title: Toxicological analysis of Pb and Cd by ET AAS in local
anaesthetics for teething (teething gels) based on herbs
available in Polish pharmacies
Authors: Kamil Jurowski, Mirosław Kros´niak, Maria Fołta,
Michael Cole, Wojciech Piekoszewski
PII: S0946-672X(18)30433-4
DOI: https://doi.org/10.1016/j.jtemb.2018.11.005
Reference: JTEMB 26253
To appear in:
Received date: 5 July 2018
Revised date: 17 September 2018
Accepted date: 6 November 2018
Please cite this article as: Jurowski K, Kros´niak M, Fołta M, Cole M, Piekoszewski
W, Toxicological analysis of Pb and Cd by ET AAS in local anaesthetics for teething
(teething gels) based on herbs available in Polish pharmacies, Journal of Trace Elements
in Medicine and Biology (2018), https://doi.org/10.1016/j.jtemb.2018.11.005
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
Toxicological analysis of Pb and Cd by ET AAS in local anaesthetics for teething 
(teething gels) based on herbs available in Polish pharmacies  
 
Kamil Jurowskia,b*, Mirosław Krośniakc, Maria Fołtac, Michael Coled, Wojciech 
Piekoszewskie,f  
 
aIndependent Researcher 
kamil.jurowski@gmail.com (corresponding author) 
b Faculty of Health Promotion, Kraków Higher School of Health Promotion, Krowoderska 73, 
31-158 Kraków, Poland 
cDepartment of Food Chemistry and Nutrition, Medical College, Jagiellonian University, 
Medyczna 9, 30-688 Kraków, Poland 
dFaculty of Science and Technology, Anglia Ruskin University, East Road, Cambridge, 
United Kingdom. 
eDepartment of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University in 
Kraków, Gronostajowa 2, 30 – 387 Kraków, Poland 
fSchool of Biomedicine, Far Eastern Federal University, Sukhanova 8, Vladivostok, 690950, 
Russia.  
 
*Address for correspondence:  
Kamil Jurowski PhD 
Kraków Higher School of Health Promotion, Krowoderska 73, 31-158 Kraków, Poland,  
E-mail: kamil.jurowski@gmail.com, phone.: +48 694 425 577 
 
 
AC
CE
PTE
D M
AN
US
CR
IPT
2 
 
Graphical abstract 
 
 
Highlights: 
x Qualitative and quantitative toxicological analysis of Pb and Cd in teething gels based 
on herbs;  
x Safety assessment of local anaesthetics for teething (teething gels) according to  
– Pb and Cd raw results (metal per kg of gel); 
x Risk assessment of applied teething gels according to one-time administration;  
x Daily exposure of Pb and Cd in applied teething gels according to the maximum daily 
dose of the applied pharmaceutical. 
 
Abstract: 
Studies related to the toxicological analyses of metallic impurities in pharmaceuticals 
(drugs) is an important issue but there is a lack of refereed literature around the safety of 
teething remedies from herbal origin related to toxic metals impurities. In this article, the 
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levels of Pb and Cd were measured in samples of local anaesthetics for teething (gels) based 
on herbs. This article was motivated by the fact that Pb and Cd are relevant toxic metals that 
may cause an adverse effect in babies even at low levels. Additional justifications were (1) the 
insufficient control of metal impurities in teething gels, (2) the lack of sufficient validation 
steps and (3) the inadequate sensitivity of applied analytical techniques. The aim of this 
article was a qualitative and quantitative analysis of Pb and Cd in the most popular and 
available local anaesthetic for teething (teething gels) based on herbs (n = 5) available in 
Poland. Metals were determined by ET AAS (electrothermal atomization atomic absorption 
spectrometry), after digestion in a microwave unit using concentrated nitric acid. It was 
observed that all samples contained Pb and Cd. The levels of Pb and Cd as impurities 
(independently of the producer and declared composition) are similar. The concentrations of 
Pb and Cd, at ng/day levels, to which the user is exposed at daily doses meet the standards of 
the directive ICH Q3D. 
Keywords: 
atomic absorption spectrometry, metal analysis, teething gels, metals impurities, infants 
 
Abbreviations: 
AAS – atomic absorption spectrometry, ET – electrothermal atomization,  
ICH Q3D – International Council for Harmonization of Technical Requirements for 
Pharmaceuticals for Human Use, PDE – permitted daily exposure, SD – standard deviation, 
US EPA – the United States Environmental Protection Agency, WHO – World Health 
Organisation. 
 
1. Introduction 
The impurities, including the metals Pb and Cd, in pharmaceuticals (drugs) often possess 
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unwanted toxicological effects by which any benefit from their administration may be 
outweighed [1]. Metal impurities in pharmaceuticals may arise from several sources, 
including, especially, [2]:  
x residual catalysts that were added intentionally in synthesis 
x metal reagent residues; 
x impurities through interactions with processing equipment or container/closure 
systems 
x components of the drug product.  
Since metallic impurities do not provide any therapeutic benefit to the patient, their 
occurrence and levels in the pharmaceuticals (drugs) should be controlled within acceptable 
limits. Hence, monitoring of toxic metals in-process intermediates and final drug substances is 
an important activity in the modern pharmaceutical industry. There is a dearth of literature on 
the metal content of pharmaceutical products produced for infants. One of the most important 
problems are contaminations/impurities of toxic metals in teething gels. 
Without a doubt, the management of teething pain is still the most frequently sought 
teething advice nowadays [3, 4]. The timing of tooth eruption varies by as much as a half 
year. Most parents prefer to avoid applying pharmaceuticals during this process.  A wide 
range of effective teething remedies based on herbs is available in pharmacies [5]. An 
assortment of teething agents is commonly recommended for relieving the pain and 
discomfort of teething [6]. The most popular teething agents are local anaesthetics (teething 
gels) usually based on herbs. It should be noted that the main ingredients in teething gels are: 
salicylic acid, lignocaine, tannic acid, menthol, thymol, glycerol, ethanol (even up to 40%) [6] 
and also different kinds of herbs. Some of these xenobiotics have the potential to be harmful 
in overdose. However, these pharmaceuticals are safe if applied as recommended [6]. 
Moreover, the important issue is also drug interactions when additional agents are used, such 
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as herbal remedies, or preparations which contain high concentrations of ethanol [4]. The 
crucial toxicological problem can be toxic metals impurities in teething gels (local 
anaesthetics) based on herbs because herbs can be an important source of these 
contaminations. 
The aim of this article was to determine the levels of Pb and Cd in local anaesthetics for 
teething (teething gels) based on herbs, available in Polish pharmacies. The choice of metals 
was justified by their potential possibility of occurrence (based on review of the literature). 
We analyzed the five most popular teething gels based on herbs which were available in 
Polish pharmacies. Pb and Cd were determined by atomic absorption spectrometer using 
electrothermal atomization (ET AAS). The findings are interpreted in line with directive ICH 
Q3D – the ICH guideline Q3D on elemental impurities published by the European Medicines 
Agency. 
 
 
2. Materials and methods 
2.1. Reagents 
Demineralized water (Millipore) and concentrated nitric acid (65%) at spectroscopic grade 
Merck (SupraPur, Darmstadt, Germany) were used in all analytical steps. Standard solutions 
of Pb and Cd were prepared by dilution of certified standard solutions (1000 µg/L MERC of 
corresponding metal ions: Pb(NO3)2 in 0.5 mol/L HNO3, and Cd(NO3)2 in 0.5 mol/L HNO3). 
Accuracy was evaluated by using the certified reference material: Corn Flour (INCT-CF-3) 
obtained from the Institute of Nuclear Chemistry and Technology Department of Analytical 
Chemistry.  
All glass equipment and plastic materials were previously treated for 24 h in 0.5 mol/L 
nitric acid and rinsed with demineralized water. 
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2.2. Applied apparatus 
For the acid digestion of samples (section 2.5. Sample preparation for metallic elements 
analysis), a microwave oven MDS 2000 (CEM USA) and microwave-assisted digestion 
procedure was used.  
All analyses were performed on a Perkin-Elmer 5100 ZL (CT, USA) atomic absorption 
spectrometer with Zeeman background correction and electrothermal atomization.  
Measurements were made with a Cd hollow-cathode lamp of 4 mA, with the slit width set at 
0.7 nm. For Pb determination, a Pb hollow-cathode lamp of 10 mA with a slit width of 0.7 nm 
was used. The AAS operating conditions applied in studies are presented in supporting 
information - Table S1. 
Argon (purity: 99.99%) was applied as a purge gas. The time-temperature program of the 
graphite furnace for analyzed metals is shown in supporting information – Table S2. and 
Table S3. 
 
2.3. Samples 
The five most popular and available teething gels based on herbs were analyzed. The 
teething gels were chosen based on the results of paediatricians’ opinions from Kraków, a 
questionnaire from 15 parents (27 – 36 years old) from Niepołomice (Poland) and a literature 
overview.. All products were purchased in pharmacies (drugstores) in Kraków or 
Niepołomice (Poland). To maintain the highest methodological standards, each 
pharmaceutical was coded (A, B and so on). A short description of the samples (declared 
ingredients) is given in the supporting information – Table S4. 
2.4. Sampling 
A representative sample from the original packaging of each product was collected for the 
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analyses. To avoid potential contamination during the analytical procedure, all steps of the 
analytical procedure were carried out in plastic equipment. Each sample was homogenized 
before weighing for the analysis. The first few centimetres of the gel were discarded since 
some products in their tubes have an aluminium lid which could also be a source of metal 
contamination. 
 
2.5. Sample preparation  
Microwave-assisted digestion was used to prepare samples using wet digestion,  
in 5.0 mL of nitric acid and about 0.3g gel sample. The details of the microwave-assisted 
digestion procedure are included in supporting information – Table S5. The solutions 
obtained were diluted in volumetric flasks to 20 mL using demineralized water and kept as 
stock sample solutions at room temperature (20 – 25 °C) until analysis. 
 
2.6. Pb and Cd analysis procedure 
The basic workflow of the quantitative analysis of Pb and Cd in teething gels is presented 
in Figure 1. 
 
2.7. Analytical calibration and quality control approaches 
The linear range of calibration function reached from the detection limit up 0.0; 1.0; 2.0; 
5.0; 10.0 Pb µg/L and 0.0; 0.5; 1.0; 2.0 µg/L for Cd. The  values of the correlation coefficient 
(R) are good indicators of the linearity for AAS instruments giving precise and accurate 
results [7, 8]. The correlation coefficients obtained (0.998 for Pb and 0.998 for Cd) indicated 
that the analyses were both precise and accurate.  
The recoveries were 97.0 % for Pb and 96.5 % for Cd. The recoveries were calculated as 
the quotient of the determined level and the known amount of the determined element 
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expressed as a percentage. 
The limit of detection (LOD) is defined as (3 SD)/a, where SD is the standard deviation 
corresponding to ten blank injections and “a” is the slope of the calibration function, obtained 
for each metal. The calculated LOD’s were 0.45 µg/L for Pb and 0.15 µg/L for Cd. On the 
other hand, LOQ is defined as (10 SD)/a, where SD is the standard deviation corresponding to 
ten blank injections and “a” is the slope of the calibration curve, obtained for each heavy 
metal.  The calculated LOQs were 0.91 µg/L for Pb and 0.30 µg/L for Cd. 
The quality control and validation of applied methodology are confirmed by previously 
described studies [9, 10] using the same methodology and apparatus. 
 
2.8. Data processing 
All analyses were performed in triplicate. The mean and standard deviation (SD) were 
calculated from these measurements. Data were analyzed using Microsoft Office Excel 2016 
for Windows.  
 
3. Results 
The results for Pb and Cd can be presented according to two approaches:  
1) raw results, i.e. metal per kg of gel; 
2) levels of metals in one dose (about one drop of teething gel applied in one administration). 
These approaches are important because it is possible to obtain information about: 
x the concentrations of Pb and Cd in a concentrated product (the ability to check the 
fulfilment of standards); 
x the actual amount of Pb and Cd consumed in one portion (single exposure); 
x the daily dose of Pb and Cd taking into account the maximum daily dose. 
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3.1. Raw results (metal per kg of mass) 
The triplicate results of each composite sample of teething gel (n = 5) are given in Table 1, 
as µg of toxic metal per kg of gel.  Pb and Cd were determined in all analyzed samples. Pb 
levels were highest in sample A (39.81 ± 8.41 µg/kg) and sample D (43.93 ± 3.10 µg/kg) – 
approximately two times higher than in other samples (18.68 – 21.77 µg/kg). The Cd levels 
were similar for all pharmaceuticals (6.98 – 9.90 µg/kg). 
 
3.2. One-time administration of applied teething gels 
While the raw results of Pb and Cd in the teething gels are extremely important due to the 
safety assessment of metal impurities in pharmaceuticals, the more valuable information from 
a consumer point of view is the actual level in the one-time administration of the product (in 
the appropriate amount of gel applied with a single administration). Based on information in 
the leaflet for each pharmaceutical, a drop of pea-sized gel should be applied to the painful 
area with a clean finger. Hence, the average volume of one drop was calculated as 
approximately 0.15 g of each gel. The calculated levels of Pb and Cd in the one-time 
administration of applied teething gels are presented in Table 2. These results are also 
necessary for the calculation of the daily exposure of Pb and Cd (the maximum daily dose of 
applied pharmaceuticals). 
 
3.2. Daily exposure of Pb and Cd in applied teething gels according to the maximum daily 
dose of applied pharmaceuticals 
The application of teething gels in the infancy period is very individual and depends on 
many different factors. For safety assessment of this pharmaceutical type calculation of the 
maximum daily dose of applied pharmaceuticals is necessary. Usually, the application of each 
gel should be repeated three times a day (up to six times), especially after meals and before 
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falling asleep. The daily exposures to Pb and Cd through applied teething gels were calculated 
considering the maximum use during the day – Table 3. The daily intake of Cd is relatively 
constant between gels (6.28 – 8.91 ng/day). On the other hand, the Pb levels were more 
variable ranging from16.81 to 39.53 ng/day.  
 
4. Discussion 
Pb and Cd are metals which are significantly cumulatively toxic. Infants may be 
particularly sensitive to the toxic effects of metals because they tend to absorb a higher 
fraction of an oral dose, and and because of their developing body systems (especially the 
nervous system) [11]. Healthy infants are likely to receive proportionately lower doses of 
pharmaceutical products and, although the proposed limits apply principally to adults, they 
have been set at a sufficiently low level to be applicable to younger age groups [11].  
It should be noted that chapter the Heavy metals (2.4.8) in the 9th Edition of the European 
Pharmacopoeia has been deleted from individual monographs on substances for 
pharmaceutical use, except those for veterinary use only. This was described in two press 
releases: 1) European Pharmacopoeia on elemental impurities (April 2015) [12] and 2) 
European Pharmacopoeia on elemental impurities - clarification for products outside the 
scope of the ICH Q3D (International Council for Harmonization of Technical Requirements 
for Pharmaceuticals for Human Use) guideline (August 2015) [13].  This completes the first 
step of the European Pharmacopoeia strategy for the implementation of the Directive ICH 
Q3D guideline on elemental impurities. This directive aims to limit the presence of toxic 
metals in pharmaceutical products intended for human use [2].  
 
4.1. Cadmium 
Based on permitted concentrations for cadmium impurities in pharmaceutical products 
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(oral concentration) recommended by directive ICH Q3D (0.5 µg/g [2]), all of the samples 
analyzed (see Table 1) meet the guidelines.  
It should be noted that a sensitive endpoint for oral exposure to cadmium and cadmium 
salts is renal toxicity [14]. Additionally, skeletal and renal effects are observed at similar 
exposure levels and are a sensitive marker of exposure to this element [15]. Since many 
studies around oral exposure to Cd in rats and mice showed no evidence of carcinogenicity, 
the renal toxicity endpoint was used to establish the oral permitted daily exposure (PDE) for 
this element, i.e. 5.0 µg/day. The results of this study (see Table 3) show that all samples 
analyzed are characterized by results below the PDE.  
 
4.2. Lead 
Considering the concentration limits for lead impurities in pharmaceuticals via oral 
concentration recommended by directive ICH Q3D (0.5 µg/g [2]), all of the samples analyzed 
(see Table 1) meet the guidelines. 
It is important that adverse neurobehavioral effects (blood lead levels <5 μg/dL) should 
considered the most sensitive and relevant endpoint in humans after oral exposure for lead 
[16]. Taking in to account the US EPA model (Integrated Exposure Uptake Biokinetic 
(IEUBK) Model) [17] based on the assumption of 100% absorption (no other sources of lead), 
oral intake of 5 μg/day translates into a blood level of 1 – 2 μg/dL for children age 0-7 years. 
Hence, PDE for this element should be taken as 5.0 µg/day. The results of this study (see 
Table 3) shows that all analyzed samples are characterized by results below PDE.  
 
5. Conclusions 
The measured levels of Pb in teething gels avaiable in Polish Pharmacies range from 16.81 
µg/kg  to 39.53 µg/kg. The levels of Cd range from 6.28 to 8.91 µg/kg. It can be assumed that 
12 
 
the Pb and Cd levels in all of the gels tested occur at a very low level (gel, µg/kg). Their 
content in a single administration is also very low (0.15 ng/g) and is not a threat to infants. 
None of the teething gels analyzed represents a health hazard to the infants. Moreover, the 
levels of  Cd and Pb meet the standards of directive ICH Q3D. Hence, considering the daily 
dose of Pb and Cd (gel, ng/day), the results are satisfactory and confirm the safety of teething 
gels for infants. It would be valuable to carry out a broader study considering other teething 
medicaments containing herbs (for example from other countries) to build upon this data. .  
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Fig. 1. The basic workflow of toxicological analysis of two toxic metals – Cd and Pb in 
teething gels. 
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Table 1. The concentrations of Pb and Cd in analyzed samples (gels, µg/kg); SD – standard 
deviation. 
Sample Pb concentration, µg/kg Cd concentration, µg/kg 
No. Code Mean SD Mean SD 
1. A 39.81 8.41 7.30 0.62 
2. B 18.68 3.90 6.98 0.84 
3. C 21.24 1.77 6.99 0.03 
4. D 43.93 3.10 9.90 0.07 
5. E 21.77 5.01 8.91 0.64 
 
Table 2. The concentration of Cd and Pb in analyzed samples (gel, ng/0.15 g) including one-
time administration. 
Sample Cd concentration, ng/0.15 g Pb concentration, ng/0.15 g 
No. Code Mean Mean 
1. A 1.10 5.97 
2. B 1.05 2.80 
3. C 1.05 3.19 
4. D 1.48 6.59 
5. E 1.34 3.27 
 
Table 3. A daily dose of Cd and Pb in analyzed samples (gel, ng/day) 
Sample Cd daily intake, ng/day Pb daily intake, ng/day 
No. Code Mean Mean 
1. A 6.57 35.82 
2. B 6.28 16.81 
3. C 6.28 19.12 
4. D 8.91 39.53 
5. E 8.02 19.60 
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